Positions

Selected Publications

Academic Article

Year Title Altmetric
2019 Second-Chance Placement of Hemodialysis Patients After Involuntary Discharge for Disruptive Behavior.  American Journal of Kidney Diseases.  74:544-548. 2019
2019 JC viruria is associated with reduced risk of diabetic kidney disease.  Journal of Clinical Endocrinology and Metabolism.  104:2286-2294. 2019
2019 Genome-wide association study identifies novel loci for type 2 diabetes-Attributed end-stage kidney disease in African Americans.  Human Genomics.  13. 2019
2017 A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis.  Kidney International Reports.  2:800-810. 2017
2016 Selecting SNPs informative for African, American Indian and European Ancestry: Application to the Family Investigation of Nephropathy and Diabetes (FIND).  BMC Genomics.  17. 2016
2015 Dialysate content and risk of sudden cardiac death.  Current Opinion in Nephrology and Hypertension.  24:557-562. 2015
2015 Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND).  PLoS Genetics.  11. 2015
2014 Nephrotoxic effects of common and emerging drugs of abuse.  Clinical Journal of the American Society of Nephrology.  9:1996-2005. 2014
2014 Quality of life and outcomes in African Americans with CKD.  Journal of the American Society of Nephrology.  25:1849-1855. 2014
2013 AKI associated with synthetic cannabinoids: A case series.  Clinical Journal of the American Society of Nephrology.  8:523-526. 2013
2012 Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.  American Journal of Kidney Diseases.  59:210-221. 2012
2012 Quality of life and psychosocial factors in African Americans with hypertensive chronic kidney disease 2012
2011 Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease.  Kidney International.  80:670-678. 2011
2010 Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease.  Kidney International.  77:1010-1019. 2010
2009 Genome-wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations - Significant evidence for linkage on chromosome 4q in African Americans: The family investigation of nephropathy and diabetes research group 2009
2009 Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.  Archives of Internal Medicine.  169:1587-1594. 2009
2008 MYH9 is associated with nondiabetic end-stage renal disease in African Americans.  Nature Genetics.  40:1185-1192. 2008
2008 The Effect of Peritoneal Dialysate on DXA Bone Densitometry Results in Patients with End-Stage Renal Disease.  Journal of Clinical Densitometry.  11:532-536. 2008
2008 Metabolic Syndrome, Proteinuria, and the Risk of Progressive CKD in Hypertensive African Americans.  American Journal of Kidney Diseases.  51:732-740. 2008
2007 Reliability of urinary albumin, total protein, and creatinine assays after prolonged storage: The family investigation of nephropathy and diabetes.  Clinical Journal of the American Society of Nephrology.  2:1156-1162. 2007
2006 Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.  Archives of Internal Medicine.  166:797-805. 2006
2001 Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: A Randomized Controlled Trial 2001
2001 Non-anemic homozygous β thalassemia in an african-american family: Association of high fetal hemoglobin levels with β thalassemia alleles.  American Journal of Hematology.  68:43-50. 2001
2000 Homocysteine Elevation in Sickle Cell Disease.  Journal of the American College of Nutrition.  19:608-612. 2000
2000 Extraskeletal calcification in patients with chronic kidney failure. 2000
2000 Reactive species in sickle cell disease.  Annals of the New York Academy of Sciences.  899:375-391. 2000
1993 A case study of a recent decline in the dialysis fatality rate..  Contributions to Nephrology.  102:59-72. 1993
1992 Lithium toxicity associated with a trichobezoar.  Annals of Internal Medicine.  116:739-740. 1992
1990 Peritonitis due to Aspergillus niger: Diagnostic importance of peritoneal eosinophilia.  Peritoneal Dialysis International.  10:100-101. 1990
1982 Acetazolamide inhibition of renal γ-glutamyl transpeptidase.  Biochemical Pharmacology.  31:3347-3352. 1982
1981 Acetazolamide (Az) inhibition of renal χ-glutamyltransferase.  The FASEB Journal.  40. 1981
1979 Glutathione inhibition of renal ammonia production.  The FASEB Journal.  38. 1979
1978 Regulation of renal glutamine utilization by glutathione.  Physiologist.  21:120. 1978

Chapter

Year Title Altmetric
2013 Disorders of calcium, phosphorus, and magnesium.  103-116. 2013

Principal Investigator On

  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2019 - 2021
  • Private Grant  awarded by MALLINCKRODT, INC. 2016 - 2019
  • Private Grant  awarded by Genzyme Corporation 2013 - 2015

    • Investigator On

  • Private Grant  awarded by VISTERRA, INC 2020 - 2024
  • Private Grant  awarded by GOLDFINCH BIO INC 2020 - 2023
  • Private Grant  awarded by GlaxoSmithKline 2017 - 2022
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2020 - 2022
  • Private Grant  awarded by VERTEX PHARMACEUTICALS, INC. 2020 - 2022
  • Private Grant  awarded by Pfizer Inc., U.S. Pharmaceuticals Group 2019 - 2022

    • Education And Training

  • Doctor of Medicine, Howard University 1984
  • Emory University Hospital Systems, Internship 1985
  • Emory University Hospital Systems, Residency 1987
  • UC Health - University Hospital, Postdoctoral Fellowship 1991

    • Full Name

  • Denyse Thornley-Brown